THE PREVALENCE OF POLYMORPHISMS OF SOME GENES ASSOCIATED WITH THE FUNCTION OF PLASMA-PLATELET HEMOSTASIS, WITH ASPIRIN RESISTANCE IN THE KAZAKH POPULATION
The relevance of the research topic: Aspirin is the most common antiplatelet drug in world clinical practice. It is a first-line agent in the treatment of acute forms of vascular insufficiency associated with atherosclerosis of the arteries. In addition, along with antihypercholesterol drugs, aspirin is most often used for primary and secondary prevention of these conditions. A rather common condition in a population is a decrease in the effectiveness of aspirin, defined by the term «aspirin resistance». The main cause of aspirin resistance is considered to be the genetic characteristics of patients, whose structure depends on the specific population.
Objective: To determine the frequency and structure of the genetic factors that determine an individual predisposition to develop of aspirin resistance, in patients with coronary heart disease in the Kazakh population.
Materials and methods: Design – cross-sectional clinical-genetic study. The study included 98 patients of Kazakh nationality with a diagnosis of CHD (79 men, 19 women; mean age 58.6±9.7 years). The control group consisted of almost 100 healthy person (the donor) of Kazakh nationality, comparable in sex and age to a study group. Genetic studies were performed to determine the Leu33Pro polymorphism of the β3 integrin gene (ITGB3), the Thr145Met polymorphism of the platelet glycoprotein 1b gene, α-subunit (GP1BA), C786T mutation of the gene 3 of nitric oxide synthase (NOS3), m utatsii platelet ADP-receptor (P2RY12, H1/H2);gene and integrin alpha-2 (platelet glycoprotein Ia/IIa) (ITGA2), mutation C807T (disruption of protein synthesis).
Statistical analysis. Qualitative data were compared using the χ2 test. The frequency of alleles was estimated by the method of gene counting, and χ2 was used to detect Hardy-Weinberg deviations fr om the equilibrium. Polymorphisms associated with CHD were further analyzed by multidimensional logistic regression.
The results of the study: In the control group, the frequency of the mutant allele for the studied polymorphisms was 14.5% in the ITGB3 (Leu33Pro) gene, 16.5% in the CP1BA (Thr145Met) gene, 41.5% in the NOS3 (C786T) gene, and H1/H2 (P2RY12) - 27.0%, which is significantly lower than those in the surveyed group (30.1%, 45.9%, 63.8% and 41.3%, respectively, p<0.05). The exception wasthe C807T gene (ITGA2), wh ere the differences with the group of examined patients were insignificant.
When analyzing the frequency of polymorphisms, significant frequencies of mutant alleles ITGB3, CP1BA, NOS3 in the homozygous form (OR=1,37; =1.93; =2.16, respectively, p<0.001) were revealed in patients with aspirin resistance. The frequencies of the H1/H2 gene polymorphisms differed to a lesser degree (OR = 1.15, p = 0.01) and there were no differences in the ITGA 2 gene. Wnachimaya dependence in blood fibrinogen occurred only on (and genotype GP1BA_Thr 145 Met (p = 0.040).
Findings:
1. The development of aspirin resistance in IHD patients in the Kazakh population is associated with the presence of mutations ITGB3_Leu33Pro, GP1BA_Thr145Met, NOS3_C786T and P2RY12_H1H2.
2. The largest differences in the frequency of polymorphisms are determined for the Thr145Met mutation in the GP1BA gene.
3. There are relationships among the studied polymorphisms of the GP1BA gene not only with aspirin resistance, but also with an increase in the content of fibrinogen in the blood.
Lyudmila K. Karazhanova 1,
Sholpan T. Zhukusheva 1,
Elmira I. Еsimbekova 1,
Mirgul A. Kapakova 1
1 Department of Cardiology and Interventional Arrhythmology,
State Medical University of Semey, Semey, Republic of Kazakhstan
1. Amsallem M., Manzo-Silberman S., Dillinger J.G., Sideris G., Voicu S., Bal dit Sollier C., Drouet L., Henry P. Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy. Am J Cardiol. 2015 May 1;115(9):1305-10.
2. Bhatt D.L. My Approach to the patient with CAD and aspirin resistance. Trends Cardiovasc Med. 2017 Oct;27(7):518-519.
3. Dąbrowski R., Dobrowolski M. Stable coronary artery disease - medical treatment. Pol Merkur Lekarski. 2017 Nov 23;43(257):228-231.
4. Dash D. Current Status of Antiplatelet Therapy in Acute Coronary Syndrome. Cardiovasc Hematol Agents Med Chem. 2015;13(1):40-49.
5. Floyd CN, Ferro A. Antiplatelet drug resistance: Molecular insights and clinical implications. Prostaglandins Other Lipid Mediat. 2015 Jul;120:21-7.
6. Floyd C.N., Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis. Br J Clin Pharmacol. 2014 Mar;77(3):446-57.
7. Gachet C. Antiplatelet drugs: which targets for which treatments? J Thromb Haemost. 2015 Jun;13 Suppl 1:S313-322.
8. Gallego-Fabrega C., Krupinski J., Fernandez-Cadenas I. Genestroke Consortium, Consorcio Español para el Estudio Genético del Ictus. Drug resistance and secondary treatment of ischaemic stroke: The genetic component of the response to acetylsalicylic acid and clopidogrel. Neurologia. 2015 Nov-Dec;30(9):566-73.
9. Gratsianskiĭ N.A. Antiplatelet therapy in coronary heart disease. Some problems and achivements. Kardiologiia. 2010;50(6):4-21.
10. Grove E.L., Würtz M., Thomas M.R., Kristensen S.D. Antiplatelet therapy in acute coronary syndromes. Expert Opin Pharmacother. 2015;16(14):2133-2147.
11. Han YL. Aspirin resistance in coronary heart disease: Current understandings and strategies. J Transl Int Med. 2016 Apr 1;4(1):7-10.
12. Harari R., Baber U. Optimal Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction. Interv Cardiol Clin. 2016 Oct;5(4):481-495.
13. Kunicki T.J., Williams S.A., Nugent D.J., Harrison P., Segal H.C., Syed A., Rothwell P.M. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease. Thromb Haemost. 2009 Jan;101(1):123-33.
14. Larsen S.B., Grove E.L., Neergaard-Petersen S., Würtz M., Hvas A.M., Kristensen S.D. Reduced antiplatelet effect of aspirin does not predict cardiovascular events in patients with stable coronary artery disease. J Am Heart Assoc. 2017 Aug 5;6(8).
15. Manolis AS, Manolis TA, Papadimitriou P, Koulouris S, Melita H. Combined antiplatelet therapy: still a sweeping combination in cardiology. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):136-67.
16. Michelson A.D., Bhatt D.L. How I use laboratory monitoring of antiplatelet therapy. Blood. 2017 Aug 10;130(6):713-721.
17. Mukarram O., Akhtar N., Junaid A., Mohyuddin A. A study into the genetic basis of aspirin resistance in Pakistani patients with coronary artery disease. Pak J Pharm Sci. 2016 Jul;29(4):1177-82.
18. Peng Y., Xia T.L., Li Y.M., Huang F.Y., Chai H., Wang P.J., Liu W., Zhang C., Pu X.B., Chen S.J., Chen M., Huang D.J. Fibrinogen is related to long-term mortality in Chinese patients with acute coronary syndrome but failed to enhance the prognostic value of the GRACE score. Oncotarget. 2017 Mar 28;8(13):20622-20629.
19. Pettersen A.A., Arnesen H., Seljeflot I. A brief review on high on-aspirin residual platelet reactivity. Vascul Pharmacol. 2015 Apr-Jun;67-69:6-9.
20. Ross S., Nejat S., Paré G. Use of genetic data to guide therapy in arterial disease. J Thromb Haemost. 2015 Jun;13 Suppl 1:S281-289.
21. Vasudeva K., Chaurasia P., Singh S., Munshi A. Genetic Signatures in Ischemic Stroke: Focus on Aspirin Resistance. CNS Neurol Disord Drug Targets. 2017; 16(9): 974-982.
22. Villanueva T. Optimal Duration of Antiplatelet Therapy Following Acute Coronary Syndrome. J Fam Pract. 2017 Dec;66 (12 Suppl).
23. Weng Z., Li X., Li Y., Lin J., Peng F., Niu W. The association of four common polymorphisms from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity: a meta-analysis. PLoS One. 2013 Nov 14;8(11):e78093.
24. Xu Z.H., Jiao J.R, Yang R., Luo B.Y., Wang X.F., Wu F. Aspirin resistance: clinical significance and genetic polymorphism. J Int Med Res. 2012;40(1):282-292.
25. Xue M., Yang X., Yang L., Kou N., Miao Y., Wang M., Ren J., Zhao Q. rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina Patients. Evid Based Complement Alternat Med. 2017;2017:9037094.
26. Zhang L., Ma X., You G., Zhang X., Fu Q. A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance. Sci Rep. 2017 Nov 22;7(1):16021.
27. Zhao Z., Li X., Sun S., Mei S., Ma N., Miao Z., Zhao M., Peng S. Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis. Eur J Clin Pharmacol. 2016 Oct; 72(10): 1195-1204.
Number of Views: 306
Category of articles:
Original article
Bibliography link
Каражанова Л.К., Жукушева Ш.Т., Есимбекова Э.И., Капакова М.А. Распространенность полиморфизмов некоторых генов, связанных с функцией плазменно-тромбоцитарного звена гемостаза, при аспиринорезистентности в казахской популяции // Наука и Здравоохранение. 2018. 5 (Т.20). С. 164-171. Karazhanova L.K., Zhukusheva Sh.T., Еsimbekova E.I., Kapakova M.A. The prevalence of polymorphisms of some genes associated with the function of plasma-platelet hemostasis, with aspirin resistance in the kazakh population. Nauka i Zdravookhranenie [Science & Healthcare]. 2018, (Vol.20) 5, pp. 164-171. Қаражанова Л.Қ., Жукушева Ш.Т., Есшімбекова Э.И., Қапақова М.А. Гемостаз жүйесінің плазмалы-тромбоцитарлы функциясымен байланысты гендер полиморфизмінің аспирингетөзімділігі бар қазақ популяциясы арасында таралуы // Ғылым және Денсаулық сақтау. 2018. 5 (Т.20). Б. 164-171.Related publications:
THE PREVALENCE OF POLYMORPHISMS OF SOME GENES ASSOCIATED WITH THE FUNCTION OF PLASMA-PLATELET HEMOSTASIS, WITH ASPIRIN RESISTANCE IN THE KAZAKH POPULATION
NATIONAL EXPERTISE CENTER BRANCHES AND DEPARTMENTS OF PUBLIC HEALTH PROTECTION COMMITTEE SPECIALISTS OPINIONS ABOUT THE ACTIVITIES AND STATUS OF SANITARY AND EPIDEMIOLOGICAL EXPERTISE ORGANIZATION
CONGENITAL HEART DISEASES AND CONNECTIVE TISSUE DYSPLASIA CHILDREN OF SEMEY, THE DETERMINATION THE FREQUENCY
FACTORS OF ADDICTIVE PREDISPOSITION AMONG FIRST-YEAR STUDENTS OF SEMEY STATE MEDICAL UNIVERSITY
PREVALENCE AND SEVERITY OF SOMATIC DISTRESS AND FATIGUE AMONG RESIDENTS OF EAST KAZAKHSTAN REGION EXPOSED TO RADIATION DUE TO THE ACTIVITY OF THE SEMIPALATINSK NUCLEAR TEST SITE